CompletedNot applicableNCT05757726
Early Feasibility of the Velocity™ Percutaneous PAVF System
Studying Progressive non-infectious anterior vertebral fusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Venova Medical
- Principal Investigator
- Adrian Ebner, MDSanatorio Italiano
- Intervention
- Velocity pAVF system(device)
- Enrollment
- 10 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Sanatorio Italiano, Asunción, Paraguay
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05757726 on ClinicalTrials.govOther trials for Progressive non-infectious anterior vertebral fusion
Additional recruiting or active studies for the same condition.
See all trials for Progressive non-infectious anterior vertebral fusion →